Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Organ-on-a-chip wikipedia , lookup
Cell membrane wikipedia , lookup
Endomembrane system wikipedia , lookup
Cellular differentiation wikipedia , lookup
Cytokinesis wikipedia , lookup
Signal transduction wikipedia , lookup
List of types of proteins wikipedia , lookup
Apoptosis (Programmed Cell Death) Apoptosis vs Necrosis • Level of stress, change in environment stress apoptosis necrosis Modes of Cell Death Necrosis Apoptosis • A pathological response to injury • Chromatin clumping • Mitochondria swelling and rupture • Plasma membrane lyses • Cell contents spill out • A normal physiological response to specific suicide signals • Chromatin condenses • Internucleosomal cleavage leads to laddering of DNA • Cytoplasma shrinks without membrane rupture • Blebbing of plasma and nuclear membranes • No spillage Tumor Suppressor Genes • Tumor-suppressor genes, function like brakes, keep cell numbers down, either by: 1. Inhibiting progress through the cell cycle and thereby preventing cell birth, or 2. Promoting apoptosis • When cellular tumor suppressor genes are rendered non-functional through mutation, the cell becomes malignant. Example: pRb, p53, and p16INK4a. Oncogenes • Oncogenes stimulate cells to grow (or refuse to die). • Mutated oncogenes can stimulate cells even when they are not receiving growth signals. Example: Ras, Akt, Survivin. • Amplification of oncogenes is also found in cancer. Example: MDM2. Apoptosis Signaling Pathway Cell, 2002;108:153-64 Tumor-derived mutations affecting apoptosis Protein Role in apoptosis Reference s p53 Mutated or altered expression in many cancers. Initiates the intrinsic apoptotic pathway. Vogelstein et al., 2000 p19ARF Mutated or altered expression in many cancers. Blocks MDM2 inhibition of p53. Enhances druginduced apoptosis by p53. Sherr and Weber, 2000 pRb Mutated in some cancers, and functionally Harbour and Dean, disrupted in many cancers. Inhibits E2F-mediated 2000 transcription. FLIP Overexpressed in some cancers. Prevents activation of caspase-8 and apoptosis induced by some chemotherapeutic drugs. Tepper and Seldin, 1999 Tumor-derived mutations affecting apoptosis Reference s Protein Role in apoptosis Apaf-1 Mutated and transcriptionally silenced in melanoma and leukemia cell lines. Necessary for activation of caspase-9 following cytochrome c release. Apaf-1-/- cells are chemoresistant. Soengas et al., 2001 CD95/Fas Mutated and down-regulated in lymphoid and solid tumors. Initiates the extrinsic apoptotic pathway. Loss of function is associated with resistance to drug-induced cell death. Muschen et al., 2000 TRAIL Mutated in metastatic breast cancers. Initiate the extrinsic apoptotic pathway. Mutations lead to suppression of death receptor-mediated apoptosis. Shin et al., 2001 Caspase8 Gene silenced in neuroblastomas. Activates both extrinsic and intrinsic apoptotic pathways. Silencing results in resistance to drug-induced apoptosis. Teitz et al., 2000 Tumor-derived mutations affecting apoptosis Protein Role in apoptosis Reference s Bcl2 Frequently overexpressed in many tumors. Antagonises Bax and/or Bak and inhibits mitochondrial membrane disruption. Inhibits druginduced apoptosis. Reed, 1999 MDM2 Overexpressed in some tumors. Negative regulator of p53. Inhibits drug-induced p53 activation. Sherr and Weber, 2000 IAPs Frequently overexpressed in cancer. Down regulation of XIAP induces apoptosis in chemoresistant tumors. Deveraux and Reed, 1999 NFkB Transcriptionally activates expression of antiapoptotic members of the Bcl-2 and IAP families. Can inhibit both the extrinsic and intrinsic death pathways and induce drug-resistance. Baldwin, 2001 Tumor-derived mutations affecting apoptosis Protein Role in apoptosis Ref Myc Induces proliferation in the presence of survival factors, such as Bcl-2, and apoptosis in the absence of survival factors. Evan and Vousden, 2001 Akt Frequently amplified in cancers. Phosphorylates Bad. Hyperactivation induces resistance to a range of apoptotic stimuli including drugs. Datta et al., 1999 PI3K Overexpressed in some cancers. Responsible for activation of Akt and downstream phosphorylation of Bad. Inhibition of PI3K enhances chemotherapeutic drug-induced apoptosis. Roymans and Slegers, 2001 Ras Mutated or deregulated in many cancers. Activates PI3K and downstream pathways. Induces proliferation and inhibits c-myc and drug-induced apoptosis. el-Deiry, 1997 Tumor-derived mutations affecting apoptosis Reference s Protein Role in apoptosis Bax Mutated or decreased expression in some tumors. Mediates mitochondrial membrane damage. Sufficient but not necessary for drug-induced apoptosis. Rampino et al., 1997 Bak Mutated or decreased expression in some tumors. Mediates mitochondrial membrane damage. Sufficient but not necessary for drug-induced apoptosis. Kondo et al., 2000 PTEN Mutated or altered expression in cancers. Regulates Akt activation and subsequent phosphorylation of Bad. Loss of PTEN results in resistance to many apoptotic stimuli. Di Cristofano and Pandolfi, 2000 Role of p53 in Apoptosis 1. p53 induces apoptosis through transcriptional activation of proapoptotic genes, such as Puma, Noxa, p53AIP, Bax, Apaf-1, etc. 2. It can also directly induce apoptosis by localizing to mitochondria via interaction with Bcl-2 family protein. Nat Rev Cancer, 2002;2:594-604 p53 in DNA Repair and Apoptosis Tumor Suppressor p53 • Mutated/inactivated in a majority of human cancers • p53 -/- knockout mice embryos develop normally to term but after a few weeks the young mice develop numerous malignant tumors • adenovirus introduced wild-type p53 markedly enhanced the antitumor effect of a common chemotherapeutic agent, cisplatin, in human non-small cell lung cancer cells, and in human colon cancer cells. • Effectiveness of cancer therapy correlates with the ability to induce p53-dependent apoptotic response Thank You